Evaluation of cardiovascular risk. What table to use?;Valoración del riesgo cardiovascular. ¿Qué tabla utilizar?

Atencion Primaria

Volumn 32, Issue 10, 2003, Pages 586-589

  Maiques Galán, Antonio ^a  

^a Centro de Salud Nazaret   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; CARDIOVASCULAR RISK; CONFERENCE PAPER; EVALUATION; RISK ASSESSMENT; SCORING SYSTEM;

EID: 0742306240     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0212-6567(03)79337-8     Document Type: Conference Paper

References (20)

1. Villar Álvarez F, Maiques Galán A, Brotons Cuixart C, Torcal Laguna J, Lorenzo Piqueras J, Vilaseca Canals J, et al. Prevención cardiovascular en atención primaria. Aten Primaria 2001;28(Supl 2):13-27.
2. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use multiple-risk-factor assessment equations. A statement for health care professionals from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 1999;34:1348-59.
3. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990;121:293-8.
4. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol 2003;56:253-61.
5. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
6. Anderson KM, Wilson PWF, Odell PM, Kannel WB. Un update coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
7. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz, H, Kannel WB. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998;97:1837-47.
8. Grupo de Estudio de la Diabetes en la Atención Primaria de Salud (GedapS). Guía para el tratamiento de la diabetes tipo 2 en la atención primaria. Madrid: Harcourt, 2000.
9. Wood D, De Backe G, Faegerman O, Graham I, Mancia G, Pyörala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-503.
10. Ministerio de Sanidad y Consumo. Control de la hipercolesterolemia en España, 2000. Un instrumento para la prevención cardiovascular. Madrid: Secretaría General Técnica del Ministerio de Sanidad y Consumo, 2000.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III). JAMA 2001;285:2486-97.
12. World Health Organization, International Society of Hypertension. 1999 WHO-ISH Guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
13. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-10.
14. Grundy SM. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation 1999;100:988-98.
15. Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular. Madrid: Sersa, 1996.
16. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham Coronary Heart Disease Prediction Scores: Results of a Multiple Ethnic Groups Investigation. J Am Med Assoc 2001;286:180-7.
17. Marrugat J, Fiol M, Sala J, Tormo MJ, Segura A, Muñiz J, et al. Variabilidad geográfica en España en las tasas de incidencia y mortalidad poblacionales por infarto agudo de miocardio en el estudio IBERICA. Gac Sanit 2000;14(Supl 2):81.
18. Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recomendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994;15:1300-31.
19. Britis Cardiac Society British Hyperlipidaemia Association, British Hypertensión Society, endorsed by the British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80:S1-S29.
20. Jakson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-10.